Skip to content

Medical-device intelligence

JCM: Control, Hemoglobin, Abnormal

FDA product code JCM: Control, Hemoglobin, Abnormal. View classification details, related manufacturers, 510(k) clearances, and recall records.

FDA classification ↗

Classification details

Product code
JCM
FDA device name
Control, Hemoglobin, Abnormal
Device class
2
Regulation number
864.7415
Medical specialty
Hematology
Review panel
HE

The source does not provide a definition for this entry. Consult the FDA classification and regulation reference for further detail.

Explore hematology records →
A product code groups records by FDA classification. It does not establish identical intended uses, commercial availability, or comparative device safety.

Record activity in this scope

12 clearance records and 1 recall records in the covered releases, across 9 source company names and 1 product codes. Dated history runs from Feb 4, 1982 to Nov 7, 2016.

Monthly counts through October 2026
Month510(k) decisionsRecall initiations
October 202500
November 202500
December 202500
January 202600
February 202600
March 202600
April 202600
May 202600
June 202600
July 202600
August 202600
September 202600
October 202600

Product codes represented

Code and FDA device nameClearancesRecalls
JCM · Control, Hemoglobin, Abnormal121

All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.

Clearances and recall records

13 matching records
Device / recordCompany in FDA recordSourceSource date
Tosoh Bioscience HLC-723G8 Analyzer for HbA1c testing.Z-1225-2017 · JCMTosoh Bioscience, Inc.RecallFeb 17, 2017FDA record creation date
EXTENDSURE HBFASC CONTROLK053031 · JCMCantebury Scientific , Ltd.510(k)Dec 7, 2005FDA decision date
HEMOGLOBIN F & A2 CONTROL (BETA-THALASSAEMIA CONTROL)K011389 · JCMCanterbury Health Laboratories510(k)Jun 21, 2001FDA decision date
MODIFICATION TO ABUSCREEN ONLINE FOR PHENCYCLIDINEK983704 · JCMRoche Diagnostic Systems, Inc.510(k)Feb 10, 1999FDA decision date
QUIK-SEP QUANTITIVE HEMOGLOBIN S CONTROLSK942222 · JCMIsolab, Inc.510(k)Jan 20, 1995FDA decision date
AFSC HEMO CONTROL #5331, AA2 HEMO CONTROL #5328K933086 · JCMHelena Laboratories510(k)Oct 31, 1994FDA decision date
HEMOCARD CONTROL HB-AA, AE, FAA, FAEK931234 · JCMIsolab, Inc.510(k)May 11, 1993FDA decision date
HEMOCARD(TM) CONTROLK924173 · JCMIsolab, Inc.510(k)Dec 1, 1992FDA decision date
SICKLE HEMOGLOBIN (HBA/S) CONTROL SETK913427 · JCMCreative Laboratory Products, Inc.510(k)Nov 19, 1991FDA decision date
LYPHOCHEK(R) HEMOGLOBIN A2 CONTROLK911347 · JCMBio-Rad510(k)Jun 10, 1991FDA decision date
HEMOCARD CONTROLK910431 · JCMIsolab, Inc.510(k)Mar 11, 1991FDA decision date
HELENA ABNORMAL HBA2 QUIK COLUMN CONTROLK820787 · JCMHelena Laboratories510(k)Apr 8, 1982FDA decision date
SICKLE-CHECKK820037 · JCMDiagnostic Technology, Inc.510(k)Feb 4, 1982FDA decision date

Manufacturers in these records

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 21, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗